Saranrat Wittayanukorn

United States Food and Drug Administration

MedicinePsychologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Factors that have an Impact on Abbreviated New Drug Application (ANDA) Submissions”.

Factors that have an Impact on Abbreviated New Drug Application (ANDA) Submissions

Therapeutic Innovation & Regulatory Science(2020)10.1007/s43441-020-00163-x

N/A

0.737DataRank · unranked

10 citations

Matthew Rosenberg, Andreas Schick, Meng Hu, Zhong Wang, Andrew Babiskin +3 more

Data-driven automated classification algorithms for acute health conditions: applying PheNorm to COVID-19 disease

Journal of the American Medical Informatics Association(2023)10.1093/jamia/ocad241

N/A

0DataRank · unranked

11 citations

Brian D. Williamson, David Cronkite, Daniel Park, Jill M Whitaker, Michael F McLemore +13 more